v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

PREVALENCE OF METABOLIC COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

AUTHORS:

Dr. Mashood Ahmed Khan, Dr. Danial Khalid, Dr. Hafiza Wajeeha Waheed

ABSTRACT:

Background: With increasing trends towards sedentary life style, obesity, diabetes mellitus, hypertension, and dyslipidaemia, the prevalence of metabolic syndrome (MetS) is rising in our country. In view of importance of diagnosis of MetS in day to day medical practice for early institution of life style therapies to reduce the atherosclerotic cardiovascular disease risk in susceptible population like in diabetes mellitus, this study has been undertaken to study the prevalence of metabolic syndrome in pakistani diabetes by applying National Cholesterol Education Programme/Adult Treatment panel (NCEP/ATP) III and International Diabetes Federation (IDF) criteria. Methods: This is a hospital based cross sectional study conducted in diabetes patients aged between 25-75 years of age presenting to Services Hospital, Lahore . Different components of MetS were studied in diabetes subjects and prevalence of metabolic syndrome was obtained by applying NCEP/ATP III and IDF criteria respectively. The data were collected as per preformed proforma and results analyzed by SPSS-16 software. results: The prevalence of metabolic syndrome in diabetes patients as per NCEP/ATP III and IDF criteria were 71% and 82% respectively. A higher number of cases with metabolic syndrome were detected using IDF criteria as opposed to NCEP/ATP III criteria in diabetes patients. Pakistani diabetes subjects showed high prevalence of abdominal obesity followed by hypertension. conclusions: The results of the present study show high prevalence of Mets in Pakistani diabetes patients and more number of cases can be diagnosed by applying IDF criteria as compared to NCEP/ATP III criteria.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.